Operating income decreased 210.3%
Operating income changed -210.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -210.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +19.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -1211 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -386 basis points from the comparable as-filed period.
Net income changed -300.1% from the comparable as-filed period.
Research & development changed +32.9% from the comparable as-filed period.
Revenue changed +21.3% from the comparable as-filed period.
SBC / revenue changed +320 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -107.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +38.2% from the comparable as-filed period.
Cost of revenue changed +60.1% from the comparable as-filed period.
Operating cash flow changed -106.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -92.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Trade receivables changed +30.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed -280 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -13.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +288 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +16.0% from the comparable as-filed period.
Capex / revenue changed -116 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +608 basis points from the comparable as-filed period.
Free-cash-flow margin changed -2085 basis points from the comparable as-filed period.
Operating cash-flow margin changed -2200 basis points from the comparable as-filed period.
Current assets changed +11.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed +10.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -7.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capex / revenue changed +48 basis points from the comparable as-filed period.
Stock-based compensation changed -10.3% from the comparable as-filed period.
Research & development changed +9.3% from the comparable as-filed period.
Gross profit changed +19.6% from the comparable as-filed period.
Revenue changed +23.1% from the comparable as-filed period.
Operating margin changed +1017 basis points from the comparable as-filed period.
Operating income changed +54.5% from the comparable as-filed period.
Operating cash flow changed +40.4% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Net income changed +86.1% from the comparable as-filed period.
Gross margin changed -252 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +39.3% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Cash & equivalents changed +31.2% from the comparable as-filed period.
Capital expenditure changed +162.4% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.